Orange Book product · Brand (NDA)
ACTICLATE
DOXYCYCLINE HYCLATE
At a glance
Jul 25, 2014
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 25, 2014
12 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXYCYCLINE HYCLATE
Strength
EQ 75MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 205931
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2016ACTICLATE CAPBrand (NDA)
NDA 208253 · CHARTWELL RX
- 2001DORYXBrand (NDA)
NDA 050582 · MAYNE PHARMA
- 1998PERIOSTATBrand (NDA)
NDA 050744 · COLLAGENEX
- —VIBRAMYCINBrand (NDA)
NDA 050007 · PFIZER
- 2026DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 203276 · AVET LIFESCIENCES
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 211137 · MACLEODS PHARMS LTD
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218888 · ASPIRO
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218753 · DR REDDYS
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217487 · AMNEAL
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218053 · KINDOS
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217854 · HERITAGE
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217794 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
